Graham R Foster Selected Research

Graham R Foster Research Topics

Disease

63	Infections 01/2022 - 02/2002
33	Fibrosis (Cirrhosis) 08/2019 - 02/2007
32	Chronic Hepatitis C 01/2022 - 05/2003
13	Hepatitis C 01/2022 - 05/2007
9	Liver Diseases (Liver Disease) 01/2022 - 11/2015
8	Chronic Hepatitis B 01/2020 - 10/2008
8	Virus Diseases (Viral Diseases) 01/2018 - 10/2003
6	Fatigue 01/2019 - 02/2002
4	Liver Cirrhosis (Hepatic Cirrhosis) 10/2021 - 08/2011
4	Inflammation (Inflammations) 07/2020 - 07/2011
4	Reinfection 01/2019 - 06/2011
4	Insulin Resistance 01/2018 - 07/2011
4	Neoplasms (Cancer) 01/2018 - 10/2003
4	Hepatitis B 01/2016 - 05/2007
3	Sepsis (Septicemia) 01/2020 - 05/2013
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 02/2002
3	Headache (Headaches) 01/2019 - 08/2014
3	Persistent Infection 12/2018 - 05/2003
3	Body Weight (Weight, Body) 01/2014 - 05/2003
2	Hypertension (High Blood Pressure) 01/2022 - 01/2021
2	Disease Progression 01/2019 - 01/2012
2	Hepatitis 01/2019 - 04/2011
2	Liver Neoplasms (Liver Cancer) 01/2019 - 10/2016
2	Coinfection 01/2018 - 11/2017
2	Chronic Disease (Chronic Diseases) 01/2017 - 10/2016
2	Human Influenza (Influenza) 01/2017 - 01/2010
2	Exanthema (Rash) 08/2014 - 03/2012
1	Chronic Renal Insufficiency 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Diverticular Diseases 01/2022
1	Atrial Fibrillation 10/2021
1	Stroke (Strokes) 10/2021
1	Ischemic Stroke 10/2021
1	COVID-19 01/2021
1	Pancreatitis 01/2020

Drug/Important Bio-Agent (IBA)

41	Ribavirin (Virazole)FDA LinkGeneric 01/2019 - 05/2003
39	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2004
31	InterferonsIBA 01/2020 - 05/2003
13	Pharmaceutical PreparationsIBA 10/2021 - 02/2002
13	SofosbuvirIBA 01/2019 - 05/2014
8	peginterferon alfa-2a (Pegasys)FDA Link 01/2020 - 02/2007
7	velpatasvirIBA 01/2018 - 12/2015
7	RNA (Ribonucleic Acid)IBA 11/2017 - 12/2007
7	telaprevirIBA 01/2017 - 06/2011
7	Protease Inhibitors (Protease Inhibitor)IBA 01/2017 - 02/2012
5	CytokinesIBA 01/2020 - 10/2003
5	glecaprevir and pibrentasvirIBA 08/2019 - 01/2018
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020 - 01/2016
4	Interferon Type IIBA 01/2020 - 02/2002
4	NucleotidesIBA 01/2019 - 05/2014
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
3	Hyaluronic Acid (Hyaluronan)IBA 07/2020 - 01/2016
3	elbasvirIBA 01/2020 - 11/2017
3	grazoprevirIBA 01/2020 - 11/2017
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2007
3	dasabuvirIBA 11/2018 - 01/2014
3	Ritonavir (Norvir)FDA Link 11/2018 - 01/2014
3	paritaprevirIBA 11/2018 - 01/2014
3	ombitasvirIBA 11/2018 - 01/2014
3	SimeprevirIBA 01/2017 - 02/2014
3	Tenofovir (Viread)FDA Link 01/2016 - 02/2015
3	Interferon-alpha (Interferon Alfa)IBA 01/2016 - 01/2010
3	Alanine Transaminase (SGPT)IBA 12/2013 - 02/2007
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2018
2	Type I Tumor Necrosis Factor ReceptorsIBA 07/2020 - 01/2018
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 07/2020 - 01/2018
2	Lipopolysaccharide ReceptorsIBA 07/2020 - 01/2018
2	LipopolysaccharidesIBA 01/2020 - 01/2018
2	sofosbuvir drug combination ledipasvirIBA 01/2020 - 05/2014
2	ruzasvirIBA 01/2019 - 11/2017
2	uprifosbuvirIBA 01/2019 - 11/2017
2	EnzymesIBA 01/2019 - 04/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2018 - 12/2013
2	lipopolysaccharide-binding proteinIBA 01/2018 - 01/2016
2	glecaprevirIBA 01/2018 - 01/2018
2	daclatasvirIBA 01/2018 - 01/2016
2	pibrentasvirIBA 01/2018 - 01/2018
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2017 - 08/2014
2	faldaprevirIBA 05/2016 - 06/2015
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 12/2013 - 08/2011
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2010 - 05/2003
2	Biological ProductsIBA 04/2007 - 02/2002
2	Amantadine (Aman)FDA LinkGeneric 03/2004 - 01/2004
1	C-Reactive ProteinIBA 01/2022
1	AlbuminsIBA 01/2022
1	Warfarin (Coumadin)FDA LinkGeneric 10/2021
1	Vitamin K 1 (Phylloquinone)FDA LinkGeneric 10/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	AntibodiesIBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	CeruletideIBA 01/2020
1	Arginine (L-Arginine)FDA Link 01/2020
1	P-300IBA 08/2019

Therapy/Procedure

44	Therapeutics 01/2022 - 05/2003
4	Opiate Substitution Treatment 11/2018 - 12/2016
4	Aftercare (After-Treatment) 01/2018 - 01/2012
3	Retreatment 01/2012 - 06/2011
2	Liver Transplantation 10/2016 - 03/2012
2	Transplantation 10/2016 - 05/2012
1	Contraindications 10/2021